IGC Pharma, Inc.IGCNYSE
Loading
P/E Ratio: Premium ValuationElevated
Percentile Rank43
Studio
Year-over-Year Change

Price-to-earnings ratio

Latest
-3.06
↑ 46% vs avg
Percentile
P43
Within normal range
Streak
2 yr
Consecutive declineElevated
Average
-5.68
Historical baseline
PeriodValueYoY Change
2025-3.06-42.1%
2024-2.15-38.9%
2023-1.55+50.9%
2022-3.16+62.9%
2021-8.52-222.3%
2020-2.65+84.8%
2019-17.45-99.2%
2018-8.76-35.6%
2017-6.46-112.9%
2016-3.03-